Download PDF
Thromb Haemost 1973; 29(03): 592-597
DOI: 10.1055/s-0038-1647800
Original Article
Schattauer GmbH

The Effect of Fibrinogen Degradation Products on Plasmin Activity

M Myśliwiec   *
1   Hematological Research Laboratory, Department IX, Ullevål Hospital, University Clinic, Oslo, Norway
,
H Arnesen
1   Hematological Research Laboratory, Department IX, Ullevål Hospital, University Clinic, Oslo, Norway
,
H. C Godal
1   Hematological Research Laboratory, Department IX, Ullevål Hospital, University Clinic, Oslo, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
30 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Purified fibrinogen degradation products Y, D or E were not found to exert antiplasmin activity as measured by the clot lysis time.

Spontaneous inactivation of plasmin was observed during incubation at 37° C. This inactivation was partly prevented by the presence of fibrinogen degradation products, as well as by other proteins.

* Permanent address: Haematology Clinic, Institute of Internal Diseases, Medical School, Bialystok, Poland


 

  • References

  • 1 Alkjaersig N, Fletcher A. P, Sherry S. 1962; Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. II. The significance, mechanism and consequences of defective fibrin polymerization. Journal of Clinical Investigation 41: 917.
    PubMedSearch in Google Scholar
  • 2 Arnesen H. 1970; Fibrinogen degradation products and fibrinogen to fibrin conversion. Scandinavian Journal of Haematology. Suppl 13: 245.
    PubMedSearch in Google Scholar
  • 3 Arnesen H, Godal H. C. 1973; Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products. Scandinavian Journal of Haematology 10: 232.
    PubMedSearch in Google Scholar
  • 4 Berg W. 1968; Urokinase activation of plasminogen and spontaneous inactivation of the plasmin formed. A kinetic study. Thrombosis et Diathesis Haemorrhagica 19: 145.
    PubMedSearch in Google Scholar
  • 5 Hirsch J, Fletcher A. P, Sherry S. 1965; Effect of fibrin and fibrinogen proteolysis products on clot physical properties. American Journal of Physiology 209: 415.
    PubMedSearch in Google Scholar
  • 6 Jacobsen C. D. 1964; The caseinolytic method for determination of plasminogen-plasmin in human blood plasma and serum. Scandinavian Journal of Clinical and Laboratory Investigation 16: 372.
    CrossrefPubMedSearch in Google Scholar
  • 7 Jacobsson K. 1955; Studies on the determination of fibrinogen in human blood plasma. Scandinavian Journal of Clinical Investigation, 7, Suppl 14: 1.
    PubMedSearch in Google Scholar
  • 8 Kowalski E, Kopeö M, Wegrzynowicz Z. 1964; Influence of fibrinogen degradation products (FDP) on platelet aggregation, adhesiveness, and viscous metamorphosis. Thrombosis et Diathesis Haemorrhagiea (Stuttg) 10: 406.
    PubMedSearch in Google Scholar
  • 9 Latallo Z. S, Budzyński A. Z, Lipinski B, Kowalski E. 1964; Inhibition of thrombin and of fibrin polymerization, two activities derived from plasmin-digested fibrinogen. Nature (Lond.) 203: 1184.
    CrossrefPubMedSearch in Google Scholar
  • 10 Marder Y. J, Shulman N. R, Carroll W. R. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physiocoehemical and immunological characterisation. Journal of Biological Chemistry 244: 2111.
    PubMedSearch in Google Scholar
  • 11 Nanninga L. B, Guest M. M. 1967; Preparation and properties of anticoagulant split product of fibrinogen and its determination in plasma. Thrombosis et Diathesis Haemorrhagiea, (Stuttg) 17: 440.
    PubMedSearch in Google Scholar
  • 12 Nanninga L. B, Guest M. M. 1968; Antifibrinolytic action of the anticoagulant split product of fibrinogen. Thrombosis et Diathesis Haemorrhagiea (Stuttg) 19: 526.
    PubMedSearch in Google Scholar
  • 13 Niewiarowski S, Kowalski E. 1957 Antithrombin formation during proteolysis of fibrinogen. Transactions of the 6th Congress of the European Society of Haematology, Copenhagen. 560.
    PubMedSearch in Google Scholar
  • 14 Niewiarowski S, Ream Y. J, Thomas D. T. 1970; Effect of fibrinogen derivatives on platelet aggregation. Thrombosis et Diathesis Haemorrhagiea (Stuttg.) Suppl 32: 49.
    PubMedSearch in Google Scholar
  • 15 Niléhn J. E. 1967; Split products of fibrinogen after prolonged interaction with plasmin. Thrombosis Diathesis Haemorrhagiea, (Stuttg) 18: 89.
    PubMedSearch in Google Scholar
  • 16 Ouchterlony Ö. 1958; Diffusion-in-gel methods for immunological analysis. Progress in Allergy 05: 1.
    PubMedSearch in Google Scholar
  • 17 Owren P. A. 1947; The coagulation of blood. Investigations on a new clotting factor. Acta Medica Scandinavica 128 Suppl. 194.
    PubMedSearch in Google Scholar
  • 18 Stachurska J, Latallo Z. S, Kopeö M. 1970; Inhibition of platelet aggregation by dialysable fibrinogen degradation products. Thrombosis et Diathesis Haemorrhagiea (Stuttg.) 23: 91.
    PubMedSearch in Google Scholar
  • 19 Triantaphyllopoulos D. C. 1957; Preliminary report on the anticoagulant properties of incubated fibrinogen. Proceedings of the 11th Annual Meeting, Western Group, Division of Medical Research National Research Council of Canada 11: 21.
    PubMedSearch in Google Scholar
  • 20 Triantaphyllopoulos D. C, Triantaphyllopoulos E, Chandra S. 1971; Effect of fibrin(ogen) degradation products on coagulation. Thrombosis et Diathesis Haemorrhagiea (Stuttg.), Suppl. 47: 121.
    PubMedSearch in Google Scholar